New Hampshire Senate Bill SB250

New Hampshire 2025 Regular Session

• Introduced: 1/23/25
• Refer: 1/23/25
• Report Pass: 3/13/25
• Engrossed: 3/28/25
• Refer: 3/28/25
• Report Pass: 4/30/25
• Enrolled: 6/16/25
• Chaptered: 6/24/25
• Passed: 6/24/25

Caption

Relative to pharmacist administration of long-acting injectable drugs.

Impact

If enacted, SB250 would expand the scope of practice for pharmacists, which could lead to increased accessibility of medications for patients. This might particularly benefit those with chronic health conditions that require regular injections, as they could receive their medication from a pharmacist without the need for a physician visit. The act's provisions for pharmacist administration could potentially alleviate some of the burdens on healthcare systems by improving medication continuity.

Summary

Senate Bill 250 seeks to amend the state's regulations surrounding the administration of certain long-acting controlled drugs by allowing pharmacists to administer these drugs pursuant to a prescription. This change aims to streamline healthcare delivery, particularly in settings where patients may not have immediate access to a physician. By empowering pharmacists, the bill aspires to enhance patient care and improve medication adherence for chronic conditions requiring long-acting injectable medications.

Contention

Notably, discussions surrounding SB250 have raised questions about the appropriateness of expanding pharmacists' roles. Critics may voice concerns regarding the training and qualifications required for pharmacists to administer such medications safely and effectively. Additionally, there may be concern over patient safety, particularly related to the monitoring of effects following administration, which traditionally falls within the scope of physicians. These debates touch on broader themes of patient safety, professional roles in healthcare, and regulatory oversight.